Generation of Infectious Prions Amenable to Site-specific Click Chemistry

This study demonstrates that substituting tryptophan 99 with p-azido-L-phenylalanine in PrPC enables the efficient propagation of infectious prions that retain site-specific click chemistry reactivity, thereby facilitating the targeted biochemical and biological investigation of prion infectivity.

The Gist

Imagine the prion protein as a tiny, shape-shifting origami crane. In its normal, healthy state (called PrPC), it's a delicate, folded paper crane that floats around your brain cells, doing its job. But sometimes, this crane gets "scrunched up" into a weird, rigid, and sticky shape (called PrPSc).

Once it gets scrunched up, it becomes a rogue. It doesn't just sit there; it acts like a mold, grabbing healthy cranes and forcing them to scrunch up into the same bad shape. This chain reaction creates a pile-up of sticky, misfolded proteins that destroys brain tissue, leading to fatal diseases like Mad Cow Disease or Creutzfeldt-Jakob Disease.

The Big Problem:
Scientists have always wanted to put a "GPS tracker" or a "glow-in-the-dark sticker" on these rogue prions to see exactly where they go, how they move, and what they touch inside the brain. But there's a catch: the prion is incredibly sensitive. If you try to glue a sticker onto the healthy crane before it scrunches up, the crane gets confused, refuses to change shape, and the whole experiment fails. It's like trying to paint a detailed design on a piece of clay while it's still being molded; the paint ruins the shape.

The Breakthrough:
This paper describes a clever "Trojan Horse" trick to solve this problem. The researchers didn't try to glue a giant sticker on the prion. Instead, they swapped out one tiny, invisible part of the healthy crane's DNA instructions.

1. The Invisible Handle: They replaced a single amino acid (a building block of the protein) with a special, tiny chemical "handle" called AzF. Think of this like replacing a standard screw on a toy with a tiny, magnetic socket. The toy looks and acts exactly the same, but now it has a secret place to connect things later.
2. The Transformation: They let these modified healthy cranes go through the scrunching process. Because the "handle" was so small and unobtrusive, the cranes successfully transformed into the rogue, sticky shape (PrPSc) without getting confused. The "mold" worked perfectly.
3. The Click: Once the prions were fully formed and infectious, the researchers used a technique called Click Chemistry. Imagine the "handle" is a Lego brick. Now, they snapped a giant, colorful, glowing Lego piece (a fluorescent dye or a drug) onto that handle. Because the connection is so strong and specific (like a click), it snaps right on without messing up the prion's structure.

Why This Matters:
This is a game-changer for science because it allows researchers to:

• Track the Invaders: They can now inject these "glowing" prions into mice and watch them travel through the body in real-time, like seeing a glowing ghost move through a house.
• Study the Interactions: They can use the handle to "fish out" other proteins that the prion is grabbing onto, helping them understand exactly how the disease spreads.
• Test Treatments: They can attach potential drugs to the prion to see if they stop the infection.

The Bottom Line:
For years, scientists were blindfolded when studying these deadly proteins because they couldn't tag them without breaking them. This paper shows how to sneak a tiny, invisible hook into the protein, let it turn into the dangerous form, and then snap on a giant, useful tool. It's like smuggling a key into a locked room, waiting for the door to open, and then using that key to unlock a treasure chest of new medical discoveries.

Technical Summary

1. The Problem: The "Conversion Bottleneck"

Prion diseases (e.g., CJD, scrapie) are caused by the templated conversion of the normal cellular prion protein ($PrP^C$) into a misfolded, infectious, and protease-resistant form ($PrP^{Sc}$). A major barrier to studying prion biology is the inability to site-specifically label $PrP^{Sc}$ without disrupting its structure or infectivity.

• Limitations of Current Methods: Traditional labeling methods (e.g., NHS esters) are non-specific and attach to multiple residues, altering protein function. Large tags (e.g., GFP, Myc-tags) often prevent $PrP^C$ from converting into infectious $PrP^{Sc}$, a phenomenon the authors term the "conversion bottleneck."
• Knowledge Gaps: Due to these limitations, researchers cannot easily determine the specific structural motifs regulating replication, map the cellular interactome of $PrP^{Sc}$, or longitudinally track prion neuroinvasion in vivo.

2. Methodology

The authors employed Genetic Code Expansion to introduce a non-canonical amino acid (ncAA) into the prion protein, followed by an in vitro conversion system and bioassays.

• Protein Engineering:

  • They substituted Tryptophan at position 99 (W99) of the prion protein with p-azido-L-phenylalanine (AzF), a small, bio-orthogonal amino acid reactive via click chemistry.
  • This was achieved using amber codon reassignment in E. coli strain B-95.ΔAΔfabR, co-transformed with a plasmid encoding the W99AzF PrP and a tRNA/tRNA-synthetase pair for AzF incorporation.
  • The resulting recombinant protein is referred to as AzF PrP.

• In Vitro Conversion System:

  • The authors used a continuous shaking reaction system to convert recombinant AzF PrP into two distinct conformers:
    1. Cofactor PrP$^{Sc}$: Infectious, requiring a phospholipid cofactor (phosphatidylethanolamine).
    2. Protein-only PrP$^{Sc}$: Non-infectious, generated by propagating in the absence of the lipid cofactor.
  • Serial propagation was performed for up to 26 rounds to ensure the removal of original seeds.

• Click Chemistry Labeling:

  • Post-conversion, the AzF-containing $PrP^{Sc}$ was reacted with various DBCO-conjugated ligands (e.g., AlexaFluor647, BODIPY, Cy7.5) via strain-promoted azide-alkyne cycloaddition (SPAAC).
  • The system was tested for labeling efficiency, seeding capability, and retention of infectivity.

• In Vivo Bioassay:

  • Mice (M109 bank vole PrP knock-in) were inoculated with serially propagated AzF $PrP^{Sc}$ and AF647-AzF $PrP^{Sc}$.
  • Survival curves, neuropathology (vacuolation), and biochemical analysis (Western blot) were used to assess infectivity and strain properties.

3. Key Contributions

• Overcoming the Conversion Bottleneck: The study demonstrates that a conservative substitution of W99 with AzF does not hinder the conversion of $PrP^C$ to $PrP^{Sc}$. The modified protein faithfully templates the formation of infectious prions.
• Post-Conversion Labeling: The authors established a workflow where the "clickable" handle is introduced before conversion, allowing for specific, site-directed labeling of the already formed infectious amyloid fibrils.
• Versatility: The system supports labeling with diverse ligands (fluorophores, NIR dyes) without destroying the amyloid structure or, in the case of cofactor prions, the infectivity.

4. Key Results

• Faithful Propagation: AzF PrP successfully propagated both cofactor-dependent and protein-only $PrP^{Sc}$ conformers over multiple rounds. The PK-resistant core maintained its characteristic molecular weight, indicating structural fidelity.
• Efficient Click Labeling:
  • Newly formed AzF $PrP^{Sc}$ reacted specifically with DBCO-fluorophores.
  • Labeling Efficiency: ~100% for protein-only $PrP^{Sc}$ and ~50% for cofactor $PrP^{Sc}$. The authors hypothesize that the ~50% efficiency in cofactor prions is due to steric/electrostatic clashes between bulky fluorophores in the tightly packed amyloid ladder, rather than a technical failure.
• Retention of Seeding and Infectivity:
  • AF647-labeled AzF $PrP^{Sc}$ retained the ability to seed new conversion reactions.
  • In Vivo Infectivity: Mice inoculated with AzF cofactor $PrP^{Sc}$ and AF647-AzF cofactor $PrP^{Sc}$ developed scrapie with 100% attack rates and incubation periods (~185–197 days) comparable to wild-type controls.
  • Mice inoculated with protein-only AzF $PrP^{Sc}$ did not develop disease, confirming that infectivity is strictly dependent on the cofactor, not the AzF modification.
• In Vivo Imaging: Near-Infrared (NIR) labeled AzF $PrP^{Sc}$ (Cy7.5) was successfully injected into mouse brains and visualized as distinct puncta using NIR imaging, demonstrating the potential for real-time tracking of prion inoculum in intact tissue.

5. Significance

This work represents a paradigm shift in prion research by providing the first method to generate infectious prions that are amenable to site-specific chemical modification.

• New Experimental Capabilities: Researchers can now:
  • Track prion trafficking and neuroinvasion pathways longitudinally in single animals (reducing the need for sacrifice at multiple timepoints).
  • Map the cellular interactome of $PrP^{Sc}$ via covalent immobilization.
  • Probe the structural determinants of prion strains by placing clickable handles at specific residues.
• Broader Applications: The strategy is not limited to prions; it offers a powerful tool for studying other disease-relevant amyloids (e.g., $\alpha$-synuclein in Parkinson's, Tau in Alzheimer's) where specific labeling has historically been difficult.
• Limitations: The current study is limited to recombinant prions (not natural strains) and a single residue substitution (W99). However, the authors suggest that the approach is generalizable to other aromatic residues and could be adapted for mammalian cell systems to study natural strains.

In conclusion, the authors have successfully "smuggled" a chemical handle through the conformationally sensitive prion conversion process, opening the door to a new era of precise biochemical and biological interrogation of infectious prions.